Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Combination of donepezil and quetiapine or PDE10A inhibitors provides synergic anti-BuChE activity

Nov. 4, 2020

Plexxikon discloses KAT3B and CREBBP inhibitors

Nov. 4, 2020

Neuraly receives IND clearance for phase IIb study of NLY-01 in Alzheimer's disease

Nov. 3, 2020

Epigenomics approach links neurodegeneration SNPs to genes, cells, mechanisms

Nov. 3, 2020

Insights, strategies for stabilizing dystrophin

Nov. 3, 2020

Results from SPI2 trial do not support the use of high-dose biotin for treating progressive MS

Nov. 3, 2020

Ester prodrug of a mGlu2/3 receptor agonist shows improved oral bioavailability

Nov. 3, 2020

Promising topline data presented from phase II study of BPN-14770 in fragile X syndrome

Nov. 3, 2020

Updated preclinical data presented for psychedelic molecule FT-104

Nov. 3, 2020

FDA allows InnoCare's IND for phase II evaluation of orelabrutinib in MS

Nov. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...